Pedro Gascon, MD, PhD
Hospital Clinic Barcelona
Pedro Gascon, MD, PhD, is the Director of Medical Oncology and Scientific Coordinator of the Hematology-Oncology Department at Hospital Clinic Barcelona, Spain. Dr. Gascon is board certified in Internal Medicine, Hematology, and Medical Oncology, and his main clinical interests include colorectal cancer, malignant melanoma and supportive care (anemia, hematopoietic growth factors, and bisphosphonates). His main research interests are in aplastic anemia, breast and colorectal cancer, and mechanisms of bone metastasis. Dr. Gascon has published over 140 papers in journals including the New England Journal of Medicine, Science, Blood, Proceedings of the National Academy of Sciences (PNAS), Journal of Clinical Oncology, Journal of Immunology, and Cancer Research. He is a member of the Alfa-Omega-Alfa Honor Society and, of many professional organizations and societies. Dr. Gascon has consulted for companies such as Ortho-Biotech/Jansen-Cilag, Roche Pharma, Amgen, Merck Sharp, and Dome. (This is me - Update Profile)
| 1999 - present | Director of Medical Oncology Hospital Clinic Barcelona |
|---|
GLG Study Groups with Pedro Gascon, MD, PhD(?)
| Study Group Name | Members |
|---|---|
| Herceptin Prescribers: Medical Oncologists | 75 |
| Oncologists (Spain) | 31 |
| Oncologists (EU) | 755 |
| Council Members who Treat Colon/Colorectal Cancer | 182 |
GLG NewsSM Analyses by Pedro Gascon, MD, PhD(?)
View all GLG News in Healthcare
GLG InstituteSM Seminars with Pedro Gascon, MD, PhD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Pedro Gascon, MD, PhD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

